Literature DB >> 19404613

Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice.

Dorothy G Flood1, Matthew Choinski, Michael J Marino, Maciej Gasior.   

Abstract

RATIONALE: Lithium and several antiepileptic drugs have mood-stabilizing effects in bipolar disorder and schizophrenia. Both disorders are characterized by deficits in prepulse inhibition (PPI) of the acoustic startle response.
OBJECTIVES: Using the DBA/2 model of naturally low PPI, which is reliably increased by antipsychotics, five mood stabilizers in clinical use were tested to determine whether they would also increase PPI in this model. All drugs were administered intraperitoneally (i.p.) 30 min before testing.
RESULTS: Lithium chloride (30 mg/kg), topiramate (100 and 300 mg/kg), carbamazepine (30, 60, and 100 mg/kg), valproic acid (178 and 316 mg/kg), and lamotrigine (3, 10, and 30 mg/kg) increased percent PPI. The antiepileptic drugs carbamazepine, valproic acid, and lamotrigine at high doses also decreased no-stimulus amplitudes and increased startle amplitudes. At high doses of carbamazepine, valproic acid, and lamotrigine, increases in percent PPI were independent of the increases in startle amplitude.
CONCLUSIONS: The demonstrated efficacy of five mood stabilizers in the DBA/2 model of naturally low PPI points to the translational value of this model in predicting therapeutic activity in schizophrenia and bipolar disorder of compounds with diverse mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404613     DOI: 10.1007/s00213-009-1547-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Effects of topiramate on the prepulse inhibition of the acoustic startle in rats.

Authors:  Roberto Frau; Marco Orrù; Mauro Fà; Alberto Casti; Mario Manunta; Nicola Fais; Giampaolo Mereu; Gianluigi Gessa; Marco Bortolato
Journal:  Neuropsychopharmacology       Date:  2006-06-14       Impact factor: 7.853

2.  Effects of pergolide on sensorimotor gating of the startle reflex in rats.

Authors:  N R Swerdlow; A Platten; J Shoemaker; L Pitcher; P Auerbach
Journal:  Psychopharmacology (Berl)       Date:  2001-11       Impact factor: 4.530

3.  Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.

Authors:  Ronan Depoortère; Gihad Dargazanli; Genevieve Estenne-Bouhtou; Annick Coste; Christophe Lanneau; Christophe Desvignes; Martine Poncelet; Michel Heaulme; Vincent Santucci; Michel Decobert; Annie Cudennec; Carolle Voltz; Denis Boulay; Jean Paul Terranova; Jeanne Stemmelin; Pierre Roger; Benoit Marabout; Mireille Sevrin; Xavier Vigé; Bruno Biton; Régis Steinberg; Dominique Françon; Richard Alonso; Patrick Avenet; Florence Oury-Donat; Ghislaine Perrault; Guy Griebel; Pascal George; Philippe Soubrié; Bernard Scatton
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

4.  The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

Authors:  B Olivier; C Leahy; T Mullen; R Paylor; V E Groppi; Z Sarnyai; D Brunner
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

5.  An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition.

Authors:  Jacob C Ong; Suzanne A Brody; Charles H Large; Mark A Geyer
Journal:  J Pharmacol Exp Ther       Date:  2005-08-25       Impact factor: 4.030

6.  Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.

Authors:  Gerard B Fox; Timothy A Esbenshade; Jia Bao Pan; Richard J Radek; Kathleen M Krueger; Betty B Yao; Kaitlin E Browman; Michael J Buckley; Michael E Ballard; Victoria A Komater; Holly Miner; Min Zhang; Ramin Faghih; Lynne E Rueter; R Scott Bitner; Karla U Drescher; Jill Wetter; Kennan Marsh; Martine Lemaire; Roger D Porsolt; Youssef L Bennani; James P Sullivan; Marlon D Cowart; Michael W Decker; Arthur A Hancock
Journal:  J Pharmacol Exp Ther       Date:  2004-12-17       Impact factor: 4.030

7.  Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Michele J Bongiovanni; Alaina C Neary; Laura S Tochen; Richard L Saint Marie
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

Review 8.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 9.  The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.

Authors:  Michael A Rogawski; Wolfgang Löscher
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

Review 10.  The effectiveness of anticonvulsants in psychiatric disorders.

Authors:  Heinz C R Grunze
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more
  15 in total

Review 1.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

2.  The effects of d-amphetamine, methylphenidate, sydnocarb, and caffeine on prepulse inhibition of the startle reflex in DBA/2 mice.

Authors:  Dorothy G Flood; Eva Zuvich; Michael J Marino; Maciej Gasior
Journal:  Psychopharmacology (Berl)       Date:  2010-06-12       Impact factor: 4.530

Review 3.  Predictive animal models of mania: hits, misses and future directions.

Authors:  Jared W Young; Brook L Henry; Mark A Geyer
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophrenia.

Authors:  Taro Kishi; Yasuhisa Fukuo; Tomo Okochi; Kunihiro Kawashima; Masatsugu Moriwaki; Osamu Furukawa; Kiyoshi Fujita; Giovanna M Musso; Christoph U Correll; John M Kane; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2012-03-28       Impact factor: 3.843

5.  Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy.

Authors:  D Feifel; P D Shilling; G Melendez
Journal:  J Psychopharmacol       Date:  2010-11-24       Impact factor: 4.153

6.  Auditory startle response is normal in juvenile myoclonic epilepsy.

Authors:  Melek Kandemir; Ayşegül Gündüz; Nurten Uzun; Naz Yeni; Meral Kızıltan
Journal:  Neurol Sci       Date:  2015-03-25       Impact factor: 3.307

7.  Prepulse inhibition of the startle reflex and response to antipsychotic treatments in two outbred mouse strains in comparison to the inbred DBA/2 mouse.

Authors:  Dorothy G Flood; Eva Zuvich; Michael J Marino; Maciej Gasior
Journal:  Psychopharmacology (Berl)       Date:  2011-02-08       Impact factor: 4.530

8.  Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.

Authors:  Philipp A Csomor; Katrin H Preller; Mark A Geyer; Erich Studerus; Theodor Huber; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2014-05-07       Impact factor: 7.853

9.  HDAC9 is implicated in schizophrenia and expressed specifically in post-mitotic neurons but not in adult neural stem cells.

Authors:  Bing Lang; Tahani Mohammed A Alrahbeni; David St Clair; Douglas H Blackwood; Colin D McCaig; Sanbing Shen
Journal:  Am J Stem Cells       Date:  2011-08-18

10.  Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system.

Authors:  Nobuaki Egashira; Moe Abe; Atsunori Shirakawa; Tomiko Niki; Kenichi Mishima; Katsunori Iwasaki; Ryozo Oishi; Michihiro Fujiwara
Journal:  Psychopharmacology (Berl)       Date:  2012-10-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.